EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

DENND2D serves as a novel prognostic biomarker with paradoxical protumorigenic effects in glioma

Hongxing Ye, Chao Zhang, Linghao Bu, Feng Xiao, Yuxiang Weng, Kaiyuan Huang, Zebin Fang, Weijian Fan, Hao Jiang, Yu Zhu, Renya Zhan, Xiujue Zheng und 3 weitere

Discover Oncology · 08.03.2026 · 17 (1)

DOI: 10.1007/s12672-026-04743-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 08.03.2026. Verfasst von Hongxing Ye und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

DENND2DGliomaImmunosuppressionPrognostic biomarkerTumor microenvironment

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China.
  • Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China. zypeng@csu.edu.cn.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China. zypeng@csu.edu.cn.
  • Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. 1320110@zju.edu.cn.

Förderung

  • Zhejiang Provincial Natural Science Foundation of China

Zitieren

APA

Ye, H., Zhang, C., Bu, L., Xiao, F., Weng, Y., Huang, K., Fang, Z., Fan, W., Jiang, H., Zhu, Y., Zhan, R., Zheng, X., Wang, Y., Peng, Z., & Zhang, L. (2026). DENND2D serves as a novel prognostic biomarker with paradoxical protumorigenic effects in glioma. Discover Oncology, 17(1). https://doi.org/10.1007/s12672-026-04743-5

Vancouver

Ye H, Zhang C, Bu L, Xiao F, Weng Y, Huang K, et al. DENND2D serves as a novel prognostic biomarker with paradoxical protumorigenic effects in glioma. Discover Oncology. 2026;17(1). doi:10.1007/s12672-026-04743-5

BibTeX
@article{Ye2026,
  author = {Ye, Hongxing and Zhang, Chao and Bu, Linghao and Xiao, Feng and Weng, Yuxiang and Huang, Kaiyuan and Fang, Zebin and Fan, Weijian and Jiang, Hao and Zhu, Yu and Zhan, Renya and Zheng, Xiujue and Wang, Yumin and Peng, Zhouying and Zhang, Luyuan},
  title = {DENND2D serves as a novel prognostic biomarker with paradoxical protumorigenic effects in glioma},
  journal = {Discover Oncology},
  year = {2026},
  volume = {17},
  number = {1},
  doi = {10.1007/s12672-026-04743-5}
}
Kostenlos starten →